QuidelOrtho Corp. (QDEL)$11.86

Market Cap: 1.87 BCurrency: USD

Research Snapshot

Static fundamentals, valuation context, and investor signals for QuidelOrtho Corp. (QDEL).

HEALTHCARE

MEDICAL DEVICES

DCF ready

Valuation

-53.0x

EV/FCF, N/A FCF yield

Quality

-24.5%

ROIC, -3.0% FCF margin

Growth

10.4%

5Y sales (revenue) CAGR

Balance sheet

1.4x

Debt/equity, 1.5x current ratio

Superinvestors

Top: Meridian Contrarian Fund (1.7%)

Strengths to research

Revenue compounded at 10.4% over five years.

Watchouts

Free cash flow margin is negative at -3.0%.

Annual data: 6 periods

Quarterly data: 19 periods

Stock snapshot: May 25, 2026

Static dataset: May 25, 2026

Quality Scorecard

Build-time composite score for QDEL.

Grade F

/ 100

Peer Comparison

Target stock against 8 market-cap comparable peers.

Heat map: red worst to green best


QDEL Target	QuidelOrtho Corp.	$1.9B	-0.7x	-53.0x	-24.5%	10.4%	-3.0%	N/A	N/A	N/A
ENOV	Enovis Corp.	$2.0B	-1.2x	161.2x	-42.5%	14.9%	0.9%	59.8%	5.7x	N/A
LIVN	LivaNova PLC	$2.0B	-16.6x	9.9x	-15.4%	8.2%	12.5%	67.7%	-1.1x	N/A
AHCO	AdaptHealth Corp.	$1.2B	-20.1x	12.8x	-2.2%	25.2%	6.8%	N/A	3.4x	N/A
IART	Integra LifeSciences Holdings	$1.0B	-2.2x	-48.9x	-29.2%	3.6%	-1.9%	N/A	N/A	N/A
AORT	Artivion Inc.	$1.0B	107.0x	1388.5x	1.5%	11.8%	0.2%	64.4%	2.7x	N/A
INMD	InMode Ltd.	$868.1M	9.6x	6.7x	13.7%	12.4%	22.7%	78.5%	-3.5x	N/A
ITGR	Integer Holdings Corp.	$4.1B	30.9x	49.8x	3.5%	11.5%	5.7%	27.0%	3.3x	N/A
BRKR	Bruker Corp.	$6.2B	-304.6x	178.8x	-0.2%	11.6%	1.3%	45.9%	5.4x	N/A

Financial Charts

No financial data available for QDEL (annual).

1 superinvestors own QDEL

Current quarter ownership and quarter-over-quarter share changes.

Superinvestor ownership

Fund	Shares	Value	% Portfolio	QoQ Change
Meridian Contrarian Fund Meridian Contrarian Fund	201,000	$9M	1.71%	New